{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T14:09:57Z","timestamp":1695132597720},"reference-count":14,"publisher":"Informa Healthcare","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1517\/13543784.15.9.1115","type":"journal-article","created":{"date-parts":[[2006,8,17]],"date-time":"2006-08-17T16:42:25Z","timestamp":1155832945000},"page":"1115-1117","source":"Crossref","is-referenced-by-count":3,"title":["Rituximab for refractory Wegener\u2019s granulomatosis"],"prefix":"10.1517","volume":"15","author":[{"given":"Sabina A","family":"Antoniu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2006,8,17]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1186\/ar771"},{"key":"CIT0002","first-page":"2018","volume":"16","author":"DE GROOT","year":"2001","journal-title":"Nephrol"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200112)44:12<2836::AID-ART471>3.0.CO;2-W"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1002\/art.20717"},{"key":"CIT0005","first-page":"180","volume":"173","author":"KEOGH","year":"2006","journal-title":"Am. J."},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1002\/art.20718"},{"key":"CIT0008","author":"STASI","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"CIT0009","doi-asserted-by":"crossref","unstructured":"ERIKSSON P: Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.J. Intern. Med.(2005) 257(6):540-548.","DOI":"10.1111\/j.1365-2796.2005.01494.x"},{"key":"CIT0010","doi-asserted-by":"crossref","unstructured":"BIRCK R, WARNATZ K, LORENZ HMet al.: 15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy.J. Am. Soc.Nephrol. (2003) 14(2):440-447.","DOI":"10.1097\/01.ASN.0000048716.42876.14"},{"key":"CIT0011","first-page":"1083","volume":"20","author":"SCHMITT","year":"2005","journal-title":"Nephrol"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.10.1126"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041884"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00534.x"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543784.15.9.1115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T18:40:43Z","timestamp":1555785643000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543784.15.9.1115"}},"subtitle":["KEOGH KA, YTTERBERG SR, FERVENZA FC<i>et al.<\/i>: Rituximab for refractory Wegener\u2019s granulomatosis: report of a prospective, open-label pilot trial.<i>Am. J. Respir. Crit. Care Med.<\/i>(2006)<b>173<\/b>(2):180-187."],"short-title":[],"issued":{"date-parts":[[2006,8,17]]},"references-count":14,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2006,8,17]]},"published-print":{"date-parts":[[2006,9]]}},"alternative-id":["10.1517\/13543784.15.9.1115"],"URL":"https:\/\/doi.org\/10.1517\/13543784.15.9.1115","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,17]]}}}